Status: Not yet recruiting
The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder
Participants diagnosed with tiletamine use disorder will be assigned to active or sham taVNS for 5 days. Clinical outcomes ( e.g., behavioral paradigms measures and clinical scales ) and physiological markers (e.g., EEG and ECG) will be evaluated at baseline, post-treatment, and 3-month follow-ups to determine therapeutic efficacy and mechanisms of action.
Participants needed: 30
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Shanghai Mental Health CenterUpdated: Jul 8, 2026Locations: 1
Eligibility criteria
Age 18-60 years ≥6 years of education[7.1] DSM-5 diagnosis of substance use diso...
Severe cognitive impairment History of epilepsy, brain injury, neurological dise...